Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC

ACRSACRS
2 quarters

Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in ACLARIS THERAPEUTICS INC

Yes. Vanguard Portfolio Management holds 1,465,735 shares of ACRS (Aclaris Therapeutics), worth $7.8M, as of its Q2 2026 13F filing. It reduced the position by 190,331 shares (-11.5%) from Q1 2026. Vanguard Portfolio Management has held ACRS in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$7.8M

Current Shares

1.5M

Total Value Change

+$1.5M

Total Shares Change

-190,331

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.5M
-11.5%
$7.8M0.0%$5.29
0
2026-Q1
First report
1.7M
-
$6.2M0.0%$3.75
0

Other major holders of ACRS: WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used